Delivery and feeding mode affects fecal calprotectin levels in infants < 7 months old

Early Human Development

Volumn 108, Issue , 2017, Pages 45-48

  Lee, Yoo Mi ^a   Min, Chae Yeon ^a   Choi, You Jin ^a   Jeong, Su Jin ^a  

^a CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; BIOLOGICAL MARKER;

AGE; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CESAREAN SECTION; CONTROLLED STUDY; FECES ANALYSIS; FECES LEVEL; FEMALE; HUMAN; IMMUNOADSORPTION; INFANT; INFANT FEEDING; MALE; NEWBORN; NORMAL HUMAN; QUESTIONNAIRE; VAGINAL DELIVERY; BREAST FEEDING; CHEMISTRY; FECES; INFLAMMATORY BOWEL DISEASE; METABOLISM; STATISTICS AND NUMERICAL DATA;

BIOMARKERS; BREAST FEEDING; CESAREAN SECTION; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE;

EID: 85017145146     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2017.03.014     Document Type: Article

References (24)

1. [1] Poullis, A., Foster, R., Mendall, M.A., Fagerhol, M.K., Emerging role of calprotectin in gastroenterology. J. Gastroenterol. Hepatol. 18 (2003), 756–762.
2. [2] Vermeire, S., Van Assche, G., Rutgeerts, P., Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 55 (2006), 426–431.
3. [3] Oord, T., Hornung, N., Fecal calprotectin in healthy children. Scand. J. Clin. Lab. Invest. 74 (2014), 254–258.
4. [4] Beşer, Ö.F., Sancak, S., Erkan, T., Kutlu, T., Çokuğraş, H., Çokuğraş, F.Ç., Can fecal calprotectin level be used as a markers of inflammation in the diagnosis and follow-up of cow's milk protein allergy?. Allergy, Asthma Immunol. Res. 6 (2014), 33–38.
5. [5] Orivuori, L., Mustonen, K., Goffau, M., Hakala, S., Paasela, M., Roduit, C., High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clinical & Experimental Allergy. 45 (2015), 928–939.
6. [6] Jost, T., Lacroix, C., Braegger, C.P., Chassard, C., New insights in gut microbiota establishment in healthy breast fed neonates. PLoS One, 7, 2012, e44595.
7. [7] Summerton, C.B., Longlands, M.G., Wiener, K., Shreeve, D.R., Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur. J. Gastroenterol. Hepatol. 14 (2002), 841–845.
8. [8] Kapel, N., Campeotto, F., Kalach, N., Baldassare, M., Butel, M.-J., Dupont, C., Faecal calprotectin in term and preterm neonates. J. Pediatr. Gastroenterol. Nutr. 51 (2010), 542–547.
9. [9] Li, F., Ma, J., Geng, S., Wang, J., Ren, F., Sheng, X., Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Hum. Dev. 90 (2014), 471–475.
10. [10] Dorosko, S.M., MacKenzie, T., Connor, R.I., Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeed. Med. 3 (2008), 117–119.
11. [11] Albanna, E.A., Ahmed, H.S., Awad, H.A., Stool calprotectin in necrotizing enterocolitis. Journal of Clinical Neonatology, 3, 2014, 16.
12. [12] Labaere, D., Smismans, A., Van Olmen, A., Christiaens, P., D'Haens, G., Moons, V., Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease. United European Gastroenterology Journal 2 (2014), 30–37.
13. [13] Von Roon, A.C., Karamountzos, L., Purkayastha, S., Reese, G.E., Darzi, A.W., Teare, J.P., Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am. J. Gastroenterol. 102 (2007), 803–813.
14. [14] Zhu, Q., Li, F., Wang, J., Shen, L., Sheng, X., Fecal calprotectin in healthy children aged 1–4 years. PLoS One, 11, 2016, e0150725.
15. [15] Fallani, M., Young, D., Scott, J., Norin, E., Amarri, S., Adam, R., Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 51 (2010), 77–84.
16. [16] Røseth, A., Fagerhol, M., Aadland, E., Schjønsby, H., Assessment of the neutrophil dominating protein calprotectin in feces: a methodologic study. Scand. J. Gastroenterol. 27 (1992), 793–798.
17. [17] Campeotto, F., Butel, M., Kalach, N., Derrieux, S., Aubert-Jacquin, C., Barbot, L., High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 89 (2004), F353–F355.
18. [18] Li, F., Ma, J., Geng, S., Wang, J., Liu, J., Zhang, J., Fecal calprotectin concentrations in healthy children aged 1–18 months. PLoS One, 10, 2015, e0119574.
19. [19] Catassi, C., Bonucci, A., Coppa, G., Carlucci, A., Giorgi, P., Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J. Pediatr. Gastroenterol. Nutr. 21 (1995), 383–386.
20. [20] Weaver, L., Laker, M., Nelson, R., Lucas, A., Milk feeding and changes in intestinal permeability and morphology in the newborn. J. Pediatr. Gastroenterol. Nutr. 6 (1987), 351–358.
21. [21] Taylor, S.N., Basile, L.A., Ebeling, M., Wagner, C.L., Intestinal permeability in preterm infants by feeding type: mother's milk versus formula. Breastfeed. Med. 4 (2009), 11–15.
22. [22] Wagner, C.L., Taylor, S.N., Johnson, D., Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin. Rev. Allergy Immunol. 34 (2008), 191–204.
23. [23] Stokholm, J., Thorsen, J., Chawes, B.L., Schjørring, S., Krogfelt, K.A., Bønnelykke, K., Cesarean section changes neonatal gut colonization. J. Allergy Clin. Immunol., 2016.
24. [24] Rutayisire, E., Huang, K., Liu, Y., Tao, F., The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol., 16, 2016, 86.